Leading Provider of Simulation and Modeling Software for Pharmaceutical Discovery and Development Scheduled to Present on September 13, 2010; Rodman & Renshaw Annual Global Investment Conference NYC
Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter of FY2010
New Record Fiscal Year Follows Record 1st, 2nd and 3rd Quarters; Rodman & Renshaw Annual Global Investment Conference NYC
Simulations Plus Reports Third Quarter FY2010 Financial Results
Another Record Quarter with Revenues up 15% and Earnings up 30% over Last Year’s Q3
Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010
New Record Quarter of $3.1 Million Due to Sustained Growth in Revenues
SLP Subsidiary Words+ Launches EyePro™ System
New System Enables Users to Operate Computer Simply by Looking at It
Simulations Plus Reports Second Quarter FY2010 Financial Results
Sustained Growth in Record Second Quarter and Record First Six Months
Simulations Plus Sets Date for 2nd Quarter Fiscal Year 2010 Earnings Release and Conference Call
Conference Call to be on Thursday, April 15, at 12:00 noon EDT
Simulations Plus Launches Biorelevant Solubility Database
Proprietary Data Generated by Company Provides Unique Insight Needed By Drug Developers
Simulations Plus Announces Renewed Share Repurchase Program
Up to One Million Shares over 12 Months Authorized by Board of Directors
Simulations Plus Reports First Quarter FY2010 Financial Results
Record First Quarter Sees Pharmaceutical Software and Services Revenues Jump 21%, Consolidated Earnings Up 38% from 1QFY09